CA 125 fasting state
Selected indexed studies
- Establishing reference interval of serum CA-125 for the healthy Han population in China. (BMC Cancer, 2026) [PMID:41527076]
- Laboratory predictors of survival in ovarian cancer. (Rev Assoc Med Bras (1992), 2020) [PMID:32130383]
- Randomized trial of exercise on cancer-related blood biomarkers and survival in women with ovarian cancer. (Cancer Med, 2023) [PMID:37269192]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Who could complete and benefit from the adjuvant chemotherapy regarding pancreatic ductal adenocarcinoma? A multivariate-adjusted analysis at the pre-adjuvant chemotherapy timing. (2022) pubmed
- Establishing reference interval of serum CA-125 for the healthy Han population in China. (2026) pubmed
- Laboratory predictors of survival in ovarian cancer. (2020) pubmed
- Randomized trial of exercise on cancer-related blood biomarkers and survival in women with ovarian cancer. (2023) pubmed
- [Clinical significance of serum CA 125 in patients with chronic liver diseases]. (2003) pubmed
- Effects of blood collection conditions on ovarian cancer serum markers. (2007) pubmed
- Thiol-disulfide homeostasis and ischemia modified albumin levels in patients diagnosed with ovary carcinoma. (2025) pubmed
- The diagnostic role of human epididymis protein 4 and serum amyloid-A in early-stage endometrial cancer patients. (2013) pubmed
- Postprandial increase in serum CA125 as a surrogate biomarker for early diagnosis of ovarian cancer. (2018) pubmed
- Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma. (2013) pubmed